Christopher Thompson is UK Life Sciences segment leader at CNA Hardy with over 15 years’ experience working in dedicated life science roles. Thompson joined CNA Hardy in 2015 from Chubb where he was a senior life science underwriter with responsibilities for managing the renewal book and large risk accounts. In his current role, he is responsible for managing a team of dedicated life science underwriters, alongside growing and developing the portfolio across both London and the UK regions.
Moderna’s suit against Pfizer and partner BioNtech over alleged COVID-vaccine-related patent infringement – and the targets’ countersuit – might suggest...
